Shionogi & Co

Shionogi & Co OCF Margin

The Operating Cash Flow Margin of Shionogi & Co (4507.T) as of Oct 15, 2026 is 42.74 %. In the previous year, Operating Cash Flow Margin was 44.60 % — a change of -4.16% (lower).

OCF Margin

42.74 %

YoY

-4.16%

Last updated:

Operating Cash Flow Margin of Shionogi & Co is 2026 42.74 % . Operating Cash Flow Margin of Shionogi & Co was 2025 44.60 % . It decreases by -4.16% lower compared to the previous year.

The Shionogi & Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
45.36 JPY
Jan 1, 2020
39.58 JPY
Jan 1, 2021
36.69 JPY
Jan 1, 2022
30.46 JPY
Jan 1, 2023
41.69 JPY
Jan 1, 2024
35.46 JPY
Jan 1, 2025
44.60 JPY
Jan 1, 2026
42.74 JPY
The Shionogi & Co OCF Margin history
YEAROCF MarginYoY
42.74 %-4.16%
44.60 %+25.77%
35.46 %-14.93%
41.69 %+36.87%
30.46 %-17.00%
36.69 %-7.29%
39.58 %-12.76%
45.36 %+20.47%
37.66 %+14.04%
33.02 %+0.06%
33.00 %+98.26%
16.64 %-39.34%
27.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shionogi & Co Stock analysis

What does Shionogi & Co do? The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shionogi & Co stock

Operating Cash Flow Margin of Shionogi & Co is 42.74 % in 2026.

Operating Cash Flow Margin of Shionogi & Co changed from 44.60 % to 42.74 %, representing a -4.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Shionogi & Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Shionogi & Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Shionogi & Co

All Key Metrics — Shionogi & Co